Pfizer says South African variant could significantly reduce vaccine protection
By Mykah in News
Updated 3 years ago
A lab study suggests the South African variant of the coronavirus may reduce antibody protection from the Pfizer Inc/BioNTech SE vaccine by two-thirds.